These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15780415)

  • 1. Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis.
    Roos K; Tellier G; Baz M; Leroy B; Rangaraju M
    J Infect; 2005 Apr; 50(3):210-20. PubMed ID: 15780415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.
    Buchanan P; Roos K; Tellier G; Rangaraju M; Leroy B
    Int J Antimicrob Agents; 2005 Mar; 25(3):237-46. PubMed ID: 15737519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
    Tellier G; Brunton SA; Nusrat R
    South Med J; 2005 Sep; 98(9):863-8. PubMed ID: 16217977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis.
    Buchanan PP; Stephens TA; Leroy B
    Am J Rhinol; 2003; 17(6):369-77. PubMed ID: 14750614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis.
    Luterman M; Tellier G; Lasko B; Leroy B
    Ear Nose Throat J; 2003 Aug; 82(8):576-80, 82-4, 586 passim. PubMed ID: 14503094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis.
    Roos K; Brunswig-Pitschner C; Kostrica R; Pietola M; Leroy B; Rangaraju M; Boutalbi Y
    Chemotherapy; 2002 May; 48(2):100-8. PubMed ID: 12011543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin-clavulanate in the treatment of acute bacterial sinusitis.
    Desrosiers M; Ferguson B; Klossek JM; Drugeon H; Mösges R
    Curr Med Res Opin; 2008 Jun; 24(6):1691-702. PubMed ID: 18559163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telithromycin for the treatment of acute exacerbations of chronic bronchitis.
    Fogarty C; Zervos M; Tellier G; Aubier M; Rangaraju M; Nusrat R
    Int J Clin Pract; 2005 Mar; 59(3):296-305. PubMed ID: 15857326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
    Camacho AE; Cobo R; Otte J; Spector SL; Lerner CJ; Garrison NA; Miniti A; Mydlow PK; Giguere GC; Collins JJ
    Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis.
    Henry DC; Sydnor A; Settipane GA; Allen J; Burroughs S; Cobb MM; Holley HP
    Clin Ther; 1999 Jul; 21(7):1158-70. PubMed ID: 10463514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telithromycin.
    Balfour JA; Figgitt DP
    Drugs; 2001; 61(6):815-29; discussion 830-1. PubMed ID: 11398913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ; Heyder AM; Leroy B
    J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of interfering bacteria in the nasopharynx following antimicrobial therapy of acute maxillary sinusitis with telithromycin or amoxicillin-clavulanate.
    Brook I; Hausfeld JN
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4793-4. PubMed ID: 16251334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
    Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF
    Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R; Berg O; Gehanno P; Leiberman A; Martinkenas JL; Nikolaidis P; Arvis P; Alefelder M; Reimnitz P
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis.
    Aubier M; Aldons PM; Leak A; McKeith DD; Leroy B; Rangaraju M; Bienfait-Beuzon C
    Respir Med; 2002 Nov; 96(11):862-71. PubMed ID: 12418583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.
    Hagberg L; Torres A; van Rensburg D; Leroy B; Rangaraju M; Ruuth E
    Infection; 2002 Dec; 30(6):378-86. PubMed ID: 12478329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil].
    Rubio-Terrés C; Cots JM; Domínguez-Gil A; Herreras A; Sánchez Gascón F; Chang J; Trilla A
    Rev Clin Esp; 2004 Nov; 204(11):567-73. PubMed ID: 15511402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.